Gunel, N. Et Al. 2003. Prognostic value of serum IL-18 and nitric oxide activity in breast cancer patients at operable stage. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , vol.26, no.4 , 416-421.

Gunel, N., Coskun, U., Sancak, B., Hasdemir, O., Sare, M., Bayram, O., ... Celenkoglu, G.(2003). Prognostic value of serum IL-18 and nitric oxide activity in breast cancer patients at operable stage. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , vol.26, no.4, 416-421.

Gunel, N Et Al. "Prognostic value of serum IL-18 and nitric oxide activity in breast cancer patients at operable stage," AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , vol.26, no.4, 416-421, 2003

Gunel, N Et Al. "Prognostic value of serum IL-18 and nitric oxide activity in breast cancer patients at operable stage." AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , vol.26, no.4, pp.416-421, 2003

Gunel, N. Et Al. (2003) . "Prognostic value of serum IL-18 and nitric oxide activity in breast cancer patients at operable stage." AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , vol.26, no.4, pp.416-421.

@article{article, author={N Gunel Et Al. }, title={Prognostic value of serum IL-18 and nitric oxide activity in breast cancer patients at operable stage}, journal={AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS}, year=2003, pages={416-421} }